Italia markets close in 1 hour 59 minutes

CSL Ltd (CSJ.MU)

Munich - Munich Prezzo differito. Valuta in EUR.
Aggiungi a watchlist
164,36-1,00 (-0,60%)
In data: 08:02AM CEST. Mercato aperto.
Schermo intero
Chiusura precedente165,36
Aperto164,36
Denaro163,28 x 0
Lettera164,50 x 0
Min-Max giorno164,36 - 164,36
Intervallo di 52 settimane138,30 - 192,75
Volume80
Media Volume5
CapitalizzazioneN/D
Beta (5 anni mensile)N/D
Rapporto PE (ttm)N/D
EPS (ttm)N/D
Prossima data utiliN/D
Rendimento e dividendo (futuro)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    uniQure announces achievement of $100 million milestone related to hemophilia B gene therapy

    Milestone payment triggered by first commercial sale of HEMGENIX® in U.S. by CSL BehringLEXINGTON, Mass. and AMSTERDAM, June 20, 2023 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, announced the achievement of a $100 million milestone associated with the first commercial sale of HEMGENIX® in the United States by its partner, global biotechnology leader CSL (ASX: CSL). HEMGENIX® (etranacoge

  • GlobeNewswire

    Kapruvia® (difelikefalin) recommended by England’s NICE for the treatment of adults with moderate-to-severe CKD-associated pruritus

    Recommendation will enable eligible patients in England, Wales and Northern Ireland to access the first licensed treatment for moderate-to-severe chronic kidney disease (CKD)-associated pruritus in adult patients on haemodialysisST. GALLEN, Switzerland and STAMFORD, Conn., May 18, 2023 (GLOBE NEWSWIRE) -- Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Cara Therapeutics, Inc. (Nasdaq: CARA) today announced that England’s National Institute for Health and Care Excellence (NICE) has recomme

  • GlobeNewswire

    OTC Markets Group Welcomes CSL Limited to OTCQX

    NEW YORK, April 27, 2023 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for 12,000 U.S. and international securities, today announced CSL Limited (ASX: CSL; OTCQX: CSLLY), a leading global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology, has qualified to trade on the OTCQX® Best Ma